Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Sanford Consortium for Regenerative Medicine, originally established as the San Diego Consortium for Regenerative Medicine, is a non-profit research organization located in La Jolla, California. It functions as a 'collaboratory' that integrates the stem cell research efforts of five leading institutions: UC San Diego, the Salk Institute, Scripps Research, Sanford Burnham Prebys, and the La Jolla Institute for Immunology. The consortium's primary mission is to accelerate the development of therapies and diagnostics derived from human stem cell research. Its state-of-the-art facility houses multi-disciplinary teams working on regenerative solutions for conditions such as Alzheimer's, diabetes, and cardiovascular disease. By fostering a culture of open collaboration, the organization aims to bridge the gap between basic laboratory discoveries and clinical patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on San Diego Consortium for Regenerative Medicine.